LHCGR (P22888) variants and mutations
LHCGR (also known as P22888) is a human protein-coding gene encoding a lutropin-choriogonadotropic hormone receptor protein. It responds to luteinizing hormone and chorionic gonadotropin to stimulate gonadal steroidogenesis, ovulation, and male sexual differentiation. Activating variants can cause male-limited precocious puberty, whereas loss-of-function variants cause Leydig-cell hypoplasia or infertility. This analysis covers 1,366 LHCGR variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes Leydig cell hypoplasia, type 1, familial male-limited precocious puberty, and female infertility. Example LHCGR variants include K2Q, Q3H, and Q3K.
Variant analysis overview
- Gene: LHCGR
- Protein: P22888
- UniProt accession: P22888
- Organism: Homo sapiens
- Variants analyzed: 1366
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 961 unspecified-consequence records; 1 stop retained variant; 23 frameshift variants; 166 synonymous variants; 200 missense variants; 6 stop-gained variants; 4 in-frame deletions; 1 splice-region variants; 4 substitution
- Prediction scores: 1,097 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Leydig cell hypoplasia, type 1, familial male-limited precocious puberty, female infertility, peripheral precocious puberty, Infertility, infertility disorder, anovulation, Precocious puberty in males, primary ovarian failure, Abnormality of the skeletal system, obesity disorder, disorder of sexual differentiation.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 1 domains; 7 post-translational modification sites.
- Structural context: 432 variants have structural context.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable LHCGR variants
Examples include K2Q, Q3H, Q3K, Q3L, R4Q, F5L, F5V, S6L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- K2Q (p.Lys2Gln), Ensembl rs1670180814
- Q3H (p.Gln3His), TOPMed rs1438175782, gnomAD rs1438175782, REVEL 0.12, CADD 14.40, Uncertain significance, Inborn genetic diseases
- Q3K (p.Gln3Lys), TOPMed rs1670180578, REVEL 0.11, CADD 8.14
- Q3L (p.Gln3Leu), gnomAD rs1670180472, REVEL 0.12, CADD 5.18
- R4Q (p.Arg4Gln), TOPMed rs889150477, gnomAD rs889150477, REVEL 0.11, CADD 11.20
- F5L (p.Phe5Leu), Ensembl rs1670179784, REVEL 0.15, CADD 1.09
- F5V (p.Phe5Val), Ensembl rs1572905304
- S6L (p.Ser6Leu), rs1558913953, ClinGen CA346815673, cosmic curated COSV54298, ClinVar RCV003851349, REVEL 0.09, CADD 7.00, Uncertain significance, not provided
- S6T (p.Ser6Thr), TOPMed rs1670179661
- A7V (p.Ala7Val), cosmic curated COSV54292, gnomAD rs1341588504, REVEL 0.15, CADD 10.20, Uncertain significance, Inborn genetic diseases
- L8P (p.Leu8Pro), TOPMed rs1337809465, REVEL 0.51, CADD 15.90
- L8V (p.Leu8Val), Ensembl rs1670178991
- Q9K (p.Gln9Lys), gnomAD rs1315876393, REVEL 0.12, CADD 5.79
- Q9L (p.Gln9Leu), TOPMed rs1217411859, gnomAD rs1217411859, REVEL 0.10, CADD 2.26
- Q9P (p.Gln9Pro), TOPMed rs1217411859, gnomAD rs1217411859, REVEL 0.12, CADD 1.59
- L10P (p.Leu10Pro), rs917607255, ClinGen CA47295578, ClinVar RCV003391556, gnomAD rs917607255, REVEL 0.33, CADD 12.80, Likely pathogenic, LHCGR-related disorder
- L11P (p.Leu11Pro), rs755654915, ClinGen CA1653500, ClinVar RCV003408511, ExAC rs755654915, REVEL 0.20, CADD 15.40, Likely pathogenic, LHCGR-related disorder
- K12N (p.Lys12Asn), Ensembl rs1670177605
- L16Q (p.Leu16Gln), rs4539842, ClinGen CA1653498, cosmic curated COSV54292, ClinVar RCV004584474, REVEL 0.45, CADD 23.80, Uncertain significance, See cases
- L17Q (p.Leu17Gln), cosmic curated COSV99683, gnomAD rs1244697101, REVEL 0.38, CADD 16.80
- L17R (p.Leu17Arg), gnomAD rs1244697101, REVEL 0.41, CADD 17.00
- Q18H (p.Gln18His), ExAC rs780848944, TOPMed rs780848944, gnomAD rs780848944, REVEL 0.16, CADD 1.21, Likely benign
- P19L (p.Pro19Leu), cosmic curated COSV54303, 1000Genomes rs188002889, REVEL 0.28, CADD 5.01
- P19Q (p.Pro19Gln), 1000Genomes rs188002889, REVEL 0.24, CADD 4.10
- P20L (p.Pro20Leu), cosmic curated COSV10882, TOPMed rs1558913693, gnomAD rs1558913693, REVEL 0.17, CADD 3.53
- P20Q (p.Pro20Gln), cosmic curated COSV54303, TOPMed rs1558913693, gnomAD rs1558913693, REVEL 0.17, CADD 4.34, Uncertain significance, Inborn genetic diseases
- P20S (p.Pro20Ser), NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, Variant assessed as somatic; moderate impact.
- P22S (p.Pro22Ser), TOPMed rs1278250301, gnomAD rs1278250301, REVEL 0.11, CADD 7.57
- R23G (p.Arg23Gly), rs1041883292, ClinGen CA47295573, ClinVar RCV004414978, TOPMed rs1041883292, REVEL 0.15, CADD 15.20, Uncertain significance, Inborn genetic diseases
- A24S (p.Ala24Ser), gnomAD rs1223955730, REVEL 0.08, CADD 4.56
- L25P (p.Leu25Pro), 1000Genomes rs549032969, TOPMed rs549032969, REVEL 0.46, CADD 17.70
- L25R (p.Leu25Arg), 1000Genomes rs549032969, TOPMed rs549032969, REVEL 0.21, CADD 20.50
- R26H (p.Arg26His), NCI-TCGA TCGA novel, REVEL 0.12, CADD 6.36, Variant assessed as somatic; moderate impact.
- R26L (p.Arg26Leu), TOPMed rs1670173776, REVEL 0.11, CADD 5.21
- R26S (p.Arg26Ser), Ensembl rs1670173866, REVEL 0.12, CADD 10.20
- E27K (p.Glu27Lys), rs979633619, NCI-TCGA Cosmic COSV5429, cosmic curated COSV54295, NCI-TCGA Cosmic COSV5430, REVEL 0.08, CADD 9.79, Uncertain significance
- E27Q (p.Glu27Gln), rs979633619, NCI-TCGA Cosmic COSV5429, NCI-TCGA Cosmic COSV5430, cosmic curated COSV54300, REVEL 0.04, CADD 7.45, Uncertain significance, LHCGR-related disorder
- E27V (p.Glu27Val), TOPMed rs1216217393, gnomAD rs1216217393, REVEL 0.09, CADD 16.20
- A28G (p.Ala28Gly), TOPMed rs1352747382, gnomAD rs1352747382, REVEL 0.14, CADD 16.80
- A28V (p.Ala28Val), rs1352747382, NCI-TCGA Cosmic COSV5430, cosmic curated COSV54301, TOPMed rs1352747382, REVEL 0.17, CADD 16.20, Variant assessed as somatic; moderate impact.
- C30R (p.Cys30Arg), gnomAD rs1409576736
- P31H (p.Pro31His), TOPMed rs967924637, gnomAD rs967924637, REVEL 0.60, CADD 27.40
- P31L (p.Pro31Leu), TOPMed rs967924637, gnomAD rs967924637, REVEL 0.60, CADD 28.50
- P31R (p.Pro31Arg), TOPMed rs967924637, gnomAD rs967924637, REVEL 0.64, CADD 27.70
- E32G (p.Glu32Gly), Ensembl rs2103767289, REVEL 0.32, CADD 23.20
- E32K (p.Glu32Lys), cosmic curated COSV54294, TOPMed rs1295794205, gnomAD rs1295794205, REVEL 0.38, CADD 21.80, Uncertain significance, Inborn genetic diseases
- P33S (p.Pro33Ser), rs1458995452, gnomAD rs1458995452, REVEL 0.18, CADD 23.50, Variant assessed as somatic; moderate impact.
- C34Y (p.Cys34Tyr), TOPMed rs1295870346, gnomAD rs1295870346, REVEL 0.73, CADD 27.20
- N35H (p.Asn35His), TOPMed rs1474245717
- N35S (p.Asn35Ser), gnomAD rs1163658646, REVEL 0.11, CADD 13.60
- N35Y (p.Asn35Tyr), TOPMed rs1474245717, REVEL 0.18, CADD 22.50
- V37L (p.Val37Leu), TOPMed rs1670170905, REVEL 0.13, CADD 14.30
- V37M (p.Val37Met), NCI-TCGA Cosmic COSV5429, TOPMed rs1670170905, REVEL 0.18, CADD 16.90, Variant assessed as somatic; moderate impact.
- P38S (p.Pro38Ser), NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, REVEL 0.12, CADD 17.00, Variant assessed as somatic; moderate impact.
- P38T (p.Pro38Thr), TOPMed rs1412890389, REVEL 0.13, CADD 19.50
- D39E (p.Asp39Glu), gnomAD rs1472140371, REVEL 0.10, CADD 14.00
- D39G (p.Asp39Gly), Ensembl rs2103767146
- D39N (p.Asp39Asn), cosmic curated COSV10639, ExAC rs754380548, TOPMed rs754380548, gnomAD rs754380548, REVEL 0.15, CADD 17.90
- G40C (p.Gly40Cys), rs1670170321, ClinGen CA346815472, ClinVar RCV003234828, REVEL 0.47, CADD 27.90, Uncertain significance, Leydig cell agenesis
- G40D (p.Gly40Asp), TOPMed rs926321157, REVEL 0.49, CADD 24.20
- G40R (p.Gly40Arg), Ensembl rs1670170321
- L42P (p.Leu42Pro), TOPMed rs1670169516, REVEL 0.51, CADD 24.90
- R43C (p.Arg43Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R43H (p.Arg43His), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54298, REVEL 0.34, CADD 26.60, Variant assessed as somatic; moderate impact.
- R43S (p.Arg43Ser), TOPMed rs1264896201, gnomAD rs1264896201, REVEL 0.22, CADD 20.30
- P45H (p.Pro45His), TOPMed rs1670168989, gnomAD rs1670168989, REVEL 0.26, CADD 22.80
- P45L (p.Pro45Leu), TOPMed rs1670168989, gnomAD rs1670168989, REVEL 0.44, CADD 23.20
- G46C (p.Gly46Cys), ExAC rs376613983, TOPMed rs376613983, gnomAD rs376613983, REVEL 0.24, CADD 24.10, Uncertain significance
- G46R (p.Gly46Arg), ExAC rs376613983, TOPMed rs376613983, gnomAD rs376613983, REVEL 0.26, CADD 22.70, Uncertain significance
- G46S (p.Gly46Ser), ExAC rs376613983, TOPMed rs376613983, gnomAD rs376613983, REVEL 0.18, CADD 22.20, Uncertain significance, not provided; Inborn genetic diseases
- P47L (p.Pro47Leu), Ensembl rs1572904980, REVEL 0.31, CADD 22.30
- T48A (p.Thr48Ala), ExAC rs760839238, TOPMed rs760839238, gnomAD rs760839238, REVEL 0.17, CADD 6.24, Uncertain significance
- T48M (p.Thr48Met), TOPMed rs1304063801, gnomAD rs1304063801, REVEL 0.20, CADD 10.00
- T48R (p.Thr48Arg), TOPMed rs1304063801, gnomAD rs1304063801, REVEL 0.07, CADD 7.45
- T48S (p.Thr48Ser), ExAC rs760839238, TOPMed rs760839238, gnomAD rs760839238, REVEL 0.10, CADD 4.49, Uncertain significance, Inborn genetic diseases
- A49T (p.Ala49Thr), Ensembl rs1670167773, REVEL 0.05, CADD 9.82
- A49V (p.Ala49Val), Ensembl rs1670167663, REVEL 0.12, CADD 15.20
- G50R (p.Gly50Arg), TOPMed rs372057341, gnomAD rs372057341, REVEL 0.23, CADD 23.50
- G50S (p.Gly50Ser), TOPMed rs372057341, gnomAD rs372057341, REVEL 0.16, CADD 20.20
- G50V (p.Gly50Val), Ensembl rs1670167205, REVEL 0.29, CADD 23.40
- T52I (p.Thr52Ile), TOPMed rs984685388, gnomAD rs984685388, REVEL 0.28, CADD 17.20
- T52N (p.Thr52Asn), TOPMed rs984685388, gnomAD rs984685388, REVEL 0.13, CADD 15.80
- T52S (p.Thr52Ser), TOPMed rs1385543959, gnomAD rs1385543959, REVEL 0.21, CADD 6.79
- R53* (p.Arg53Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R53Q (p.Arg53Gln), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54293, REVEL 0.47, CADD 23.40, Variant assessed as somatic; moderate impact.
- S55L (p.Ser55Leu), NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, Variant assessed as somatic; moderate impact.
- L56P (p.Leu56Pro), cosmic curated COSV54303, Ensembl rs1572875051
- L56R (p.Leu56Arg), NCI-TCGA Cosmic COSV5430, NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, Variant assessed as somatic; moderate impact.
- A57T (p.Ala57Thr), cosmic curated COSV10882, 1000Genomes rs576351203, ExAC rs576351203, REVEL 0.04, CADD 17.10
- A57V (p.Ala57Val), Ensembl rs2103631092, REVEL 0.14, CADD 23.00
- Y58* (p.Tyr58Ter), TOPMed rs1558875244, gnomAD rs1558875244, CADD 36.00
- L59H (p.Leu59His), TOPMed rs1317862877
- L59V (p.Leu59Val), gnomAD rs1668973210, REVEL 0.71, CADD 25.50
- P60L (p.Pro60Leu), cosmic curated COSV10639, gnomAD rs1268787455
- P60R (p.Pro60Arg), gnomAD rs1268787455, REVEL 0.61, CADD 22.90
- V61D (p.Val61Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K62N (p.Lys62Asn), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54295, Variant assessed as somatic; moderate impact.
- V63A (p.Val63Ala), gnomAD rs1207518766
- I64F (p.Ile64Phe), Ensembl rs1668972727
- I64T (p.Ile64Thr), TOPMed rs1668972635
- P65L (p.Pro65Leu), NCI-TCGA Cosmic COSV5430, cosmic curated COSV54301, REVEL 0.82, CADD 26.60, Variant assessed as somatic; moderate impact.
- P65S (p.Pro65Ser), cosmic curated COSV10459, ExAC rs772574574, TOPMed rs772574574, gnomAD rs772574574, REVEL 0.74, CADD 23.80
- P65T (p.Pro65Thr), ExAC rs772574574, TOPMed rs772574574, gnomAD rs772574574
- S66P (p.Ser66Pro), rs747749486, ClinGen CA1653430, ClinVar RCV002779501, ExAC rs747749486, REVEL 0.31, CADD 22.90, Uncertain significance, Inborn genetic diseases
- Q67E (p.Gln67Glu), ExAC rs780523667, gnomAD rs780523667, REVEL 0.36, CADD 23.00
- Q67L (p.Gln67Leu), TOPMed rs1190261034, gnomAD rs1190261034, REVEL 0.42, CADD 24.30
- A68D (p.Ala68Asp), TOPMed rs944199288, gnomAD rs944199288, REVEL 0.81, CADD 26.10
- A68V (p.Ala68Val), rs944199288, NCI-TCGA Cosmic COSV5429, cosmic curated COSV54291, TOPMed rs944199288, REVEL 0.66, CADD 25.60, Variant assessed as somatic; moderate impact.
- F69S (p.Phe69Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G71E (p.Gly71Glu), TOPMed rs1668971448, gnomAD rs1668971448, REVEL 0.65, CADD 24.10
- G71R (p.Gly71Arg), ExAC rs746197082, TOPMed rs746197082, gnomAD rs746197082, REVEL 0.67, CADD 25.80, Uncertain significance, not specified; not provided
- L72H (p.Leu72His), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54298, Variant assessed as somatic; moderate impact.
- L72R (p.Leu72Arg), NCI-TCGA Cosmic COSV5429, Variant assessed as somatic; moderate impact.
- E74D (p.Glu74Asp), ExAC rs757817671, gnomAD rs757817671, REVEL 0.14, CADD 16.60
- V75A (p.Val75Ala), Ensembl rs1668970999
- V75I (p.Val75Ile), Ensembl rs1466091952
- I76R (p.Ile76Arg), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54299, Variant assessed as somatic; moderate impact.
- K77Q (p.Lys77Gln), NCI-TCGA Cosmic COSV5430, cosmic curated COSV54300, Variant assessed as somatic; moderate impact.
- I78M (p.Ile78Met), ExAC rs753671958, gnomAD rs753671958, REVEL 0.77, CADD 23.70
- I78V (p.Ile78Val), rs751703778, ClinGen CA1653424, ClinVar RCV004414976, ExAC rs751703778, REVEL 0.55, CADD 29.20, Uncertain significance, Inborn genetic diseases
- E79K (p.Glu79Lys), cosmic curated COSV54293, Ensembl rs267599402
- I80M (p.Ile80Met), Ensembl rs990809960
- S81A (p.Ser81Ala), TOPMed rs1381039031, gnomAD rs1381039031, REVEL 0.58, CADD 23.80
- Q82D (p.Gln82Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Q82R (p.Gln82Arg), ExAC rs766156571, gnomAD rs766156571, REVEL 0.66, CADD 23.90
- I83M (p.Ile83Met), rs2529875013, ClinGen CA346760437, ClinVar RCV002867143, REVEL 0.30, CADD 22.80, Uncertain significance, not provided
- D84E (p.Asp84Glu), ExAC rs760722768, TOPMed rs760722768, gnomAD rs760722768, REVEL 0.61, CADD 22.10
- D84G (p.Asp84Gly), NCI-TCGA Cosmic COSV5430, cosmic curated COSV54302, Variant assessed as somatic; moderate impact.
- D84H (p.Asp84His), gnomAD rs200707752, REVEL 0.78, AlphaMissense 0.36
- D84N (p.Asp84Asn), rs200707752, NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, gnomAD rs200707752, AlphaMissense 0.36, MetaLR 0.81, Variant assessed as somatic; moderate impact.
- S85A (p.Ser85Ala), TOPMed rs957491616, gnomAD rs957491616, REVEL 0.48, CADD 23.40, Uncertain significance, Inborn genetic diseases
- L86P (p.Leu86Pro), ExAC rs750340960, TOPMed rs750340960, gnomAD rs750340960, REVEL 0.87, CADD 27.00
- E87* (p.Glu87Ter), 1000Genomes rs149019093, ExAC rs149019093, TOPMed rs149019093, gnomAD rs149019093, CADD 40.00
- E87K (p.Glu87Lys), rs149019093, NCI-TCGA Cosmic COSV5430, cosmic curated COSV54303, 1000Genomes rs149019093, REVEL 0.48, CADD 24.30, Variant assessed as somatic; moderate impact.
- R88K (p.Arg88Lys), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54297, NCI-TCGA Cosmic COSV9968, REVEL 0.11, CADD 16.70, Variant assessed as somatic; moderate impact.
- R88M (p.Arg88Met), cosmic curated COSV99684, Ensembl rs1031862205
- I89T (p.Ile89Thr), ExAC rs763880284, gnomAD rs763880284, REVEL 0.88, CADD 25.10
- E90Q (p.Glu90Gln), Ensembl rs2103621277, REVEL 0.50, CADD 21.80
- A91T (p.Ala91Thr), TOPMed rs1460068431, gnomAD rs1460068431, REVEL 0.35, CADD 24.60
- N92T (p.Asn92Thr), ExAC rs762692771, gnomAD rs762692771, REVEL 0.23, CADD 19.60
- D95E (p.Asp95Glu), ExAC rs777195872, TOPMed rs777195872, gnomAD rs777195872, REVEL 0.45, CADD 22.90
- D95G (p.Asp95Gly), gnomAD rs1450652801, REVEL 0.61, CADD 23.70
- D95H (p.Asp95His), Ensembl rs1668874032, REVEL 0.48, CADD 22.10
- D95N (p.Asp95Asn), NCI-TCGA Cosmic COSV9968, cosmic curated COSV99683, REVEL 0.28, CADD 24.20, Variant assessed as somatic; moderate impact.
- D95V (p.Asp95Val), gnomAD rs1450652801, REVEL 0.60, CADD 23.70
- N96S (p.Asn96Ser), TOPMed rs1668873542, REVEL 0.30, CADD 6.50
- L97F (p.Leu97Phe), rs2529874814, ClinGen CA346760331, ClinVar RCV003292038, REVEL 0.77, CADD 26.50, Uncertain significance, Inborn genetic diseases
- L97R (p.Leu97Arg), ExAC rs771440304, gnomAD rs771440304, REVEL 0.89, CADD 27.60
- L98F (p.Leu98Phe), cosmic curated COSV54300, 1000Genomes rs535656263, ExAC rs535656263, gnomAD rs535656263, REVEL 0.22, CADD 17.70
- L98H (p.Leu98His), gnomAD rs1430997827, REVEL 0.41, CADD 23.20
- N99S (p.Asn99Ser), ExAC rs773619386, gnomAD rs773619386, REVEL 0.25, CADD 20.30
- L100F (p.Leu100Phe), ESP rs149199738, ExAC rs149199738, TOPMed rs149199738, gnomAD rs149199738, REVEL 0.81, CADD 24.10
- E102Q (p.Glu102Gln), NCI-TCGA Cosmic COSV5429, NCI-TCGA Cosmic COSV9968, cosmic curated COSV99684, Variant assessed as somatic; moderate impact.
- I103K (p.Ile103Lys), 1000Genomes rs568148296, REVEL 0.89, CADD 29.30
- N107I (p.Asn107Ile), TOPMed rs1333043008, gnomAD rs1333043008, REVEL 0.84, CADD 26.40, Uncertain significance, Inborn genetic diseases; not provided
- T108I (p.Thr108Ile), ESP rs145919704, TOPMed rs145919704, REVEL 0.54, CADD 23.80
- T108N (p.Thr108Asn), ESP rs145919704, TOPMed rs145919704
- K109T (p.Lys109Thr), NCI-TCGA Cosmic COSV5429, cosmic curated COSV54292, REVEL 0.70, CADD 26.20, Variant assessed as somatic; moderate impact.
- N110D (p.Asn110Asp), NCI-TCGA Cosmic COSV5429, NCI-TCGA Cosmic COSV9968, cosmic curated COSV99684, Variant assessed as somatic; moderate impact.
- L111V (p.Leu111Val), gnomAD rs1229403196, REVEL 0.77, CADD 23.90
- R112T (p.Arg112Thr), ExAC rs768736086, gnomAD rs768736086, REVEL 0.14, CADD 12.30
- Y113C (p.Tyr113Cys), ESP rs370920511, ExAC rs370920511, TOPMed rs370920511, gnomAD rs370920511, REVEL 0.42, CADD 23.70
- Y113H (p.Tyr113His), ESP rs140691492, ExAC rs140691492, TOPMed rs140691492, gnomAD rs140691492, REVEL 0.17, AlphaMissense 0.61, Benign
- Y113N (p.Tyr113Asn), rs140691492, ClinGen CA1653360, cosmic curated COSV10609, ClinVar RCV000271704, REVEL 0.25, CADD 1.45, Conflicting interpretations, not provided; not specified; Leydig cell agenesis
- I114V (p.Ile114Val), ExAC rs745692187, gnomAD rs745692187, REVEL 0.58, CADD 23.70
- E115D (p.Glu115Asp), gnomAD rs1668688977, REVEL 0.27, CADD 15.20
- P116A (p.Pro116Ala), ESP rs377265035, ExAC rs377265035, TOPMed rs377265035, gnomAD rs377265035, REVEL 0.16, CADD 11.80
- P116H (p.Pro116His), NCI-TCGA Cosmic COSV5430, REVEL 0.44, CADD 24.20, Variant assessed as somatic; moderate impact.
- P116S (p.Pro116Ser), ESP rs377265035, ExAC rs377265035, TOPMed rs377265035, gnomAD rs377265035, REVEL 0.20, CADD 13.60, Uncertain significance, not provided
- P116T (p.Pro116Thr), rs377265035, ESP rs377265035, ExAC rs377265035, TOPMed rs377265035, REVEL 0.34, CADD 13.80, Variant assessed as somatic; moderate impact.
- G117A (p.Gly117Ala), ExAC rs758016158, gnomAD rs758016158, REVEL 0.68, CADD 23.60
- G117E (p.Gly117Glu), ExAC rs758016158, gnomAD rs758016158, REVEL 0.62, CADD 22.80
- G117R (p.Gly117Arg), cosmic curated COSV99683, TOPMed rs1209521626, gnomAD rs1209521626, REVEL 0.69, CADD 23.50
- A118E (p.Ala118Glu), 1000Genomes rs200591881, ExAC rs200591881, REVEL 0.88, AlphaMissense 0.96, Uncertain significance
- A118T (p.Ala118Thr), Ensembl rs1558866632
- A118V (p.Ala118Val), rs200591881, ClinGen CA346759479, ClinVar RCV001823541, 1000Genomes rs200591881, AlphaMissense 0.96, MetaLR 0.92, Uncertain significance, Leydig cell agenesis
- F119L (p.Phe119Leu), TOPMed rs1650854374, REVEL 0.93, CADD 25.90
- I120T (p.Ile120Thr), TOPMed rs1237586952, REVEL 0.12, CADD 13.70
- N121K (p.Asn121Lys), TOPMed rs993092773, REVEL 0.21, CADD 21.60
- N121S (p.Asn121Ser), NCI-TCGA Cosmic COSV5430, cosmic curated COSV54304, Variant assessed as somatic; moderate impact.
Public LHCGR analysis runs
- LHCGR analysis run — LHCGR (1,366 variants) — completed 2026-08-19